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Abstract   
Objectives: This study sought to test the acceptability and effectiveness of a transdiagnostic 
approach to treating co-morbid anxiety and depression in older adults.  Method In an A/B single 
case experimental design, a co-morbidly patient completed 5 daily ideographic measures of anxiety 
and depression across baseline and treatment and also the HADS at five time points over time.  
Treatment consisted of an 8-session intervention using the Unified Protocol (UP) conducted in 
routine practice.  Results All sessions were attended.  Significant baseline-treatment improvements 
were found in daily structure, mood, confidence and worry, with large associated effect sizes.  The 
shape of change was progressive following initiation of treatment.  The patient met recovery 
criteria by the end of treatment, but with some evidence of anxious relapse at follow-up.   
Conclusion The UP offers promise as an additional approach to treating co-morbid anxiety and 
depression in older adults and needs to be tested further via more exacting methodologies in larger 
samples.   
Keywords: Unified Protocol, Single Case Experimental Design, Older adults.   
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The majority of the progress in the psychological treatment of emotional disorders has been 
in the development and testing of treatment protocols for either anxiety or depressive disorders 
(Barlow, 2010).  Whilst the trials of such protocols have understandably excluded patients with co-
morbid anxiety in order to ensure internal validity, such co-morbidity is the norm rather the 
exception in routine clinical practice (Barlow et al., 2004; Clark and Taylor, 2009).  Co-morbidity of 
anxiety and depression in older adults is more common than each disorder independently; 50 % 
suffering from depression also display some form of anxiety disorder (King-Kallimanis, Gum, & 
Kohn, 2009).  Co-morbidity also increases impairment in daily functioning, severity of symptoms 
and likelihood of suicide (Lenze, 2003).  The Department of Health (2009) highlight that one quarter 
of older adults living in the community have symptoms of depression and anxiety serious enough to 
warrant assessment and intervention.  Testing of new clinical models that address such co-
morbidity are therefore at a premium for patients and services alike.         
 Recent research evidence suggests greater theoretical and clinical commonalities between 
anxiety and depression than previously assumed (Ellard, Fairholme, Boisseau, Farchione & Barlow, 
2010), and in particular the demonstration of the key role of negative affect (Etkin & Wagner, 
2007).  In an attempt to meet this recognition a  ?transdiagnostic ? Žƌ ?unified protocol ? (UP) has been 
developed (Barlow et al., 2004).  The UP is a manualised, brief cognitive behavioural treatment that 
formulates deficits in emotion regulation as key maintainers of anxiety and depression (Barlow et 
al., 2004), through chronic and unsuccessful attempts to avoid or dampen the intensity of negative 
affects (Ellard et al, 2010).  The UP has been tested in two open (Ellard et al., 2010) and one 
controlled trial (Farchione et al., 2012) with working age patients.  The first open trial (N=18) noted 
significant pre to post treatment effects of an early version of the UP, which were incorporated into 
the second open trial (N=15).  These results showed that 64% of co-morbid patients achieved 
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responder status, with gains maintained at follow-up (Ellard et al., 2010).  The wait-list controlled 
Farchione et al., (2012) trial noted that in comparison to controls (N=11), UP patients (N=26) 
demonstrated significant reductions in clinical severity of anxiety/depression and symptom 
interference with everyday life.   
 Although trials are frequently recognised as the gold standard in psychotherapy outcome 
research, their low external validity often limits vital transferability of findings to routine clinical 
settings (ĂƌŬŚĂŵ ?,ĂƌĚǇ ? ?DĞůůŽƌ ?ůĂƌŬ ? ? ? ? ?). Single case experimental design (SCED) is one in a 
range of complementary empirical frameworks regarding the scientific evaluation of  ?ƌĞĂů-ǁŽƌůĚ ?
psychotherapy which places minimal restrictions on inclusion criteria, thus increasing external 
validity (McMillan & Morley, 2010).  In SCED, outcomes are simultaneously measured against 
patient-centred idiographic measures in time series designs and standardised nomothetic 
psychometric indices of clinical change (Barkham, Hardy, & Mellor-Clark, 2010).  SCED is particularly 
indicated in the early testing of new clinical models or new applications of extant treatments in 
novel populations (Morley, 2008).  As SCED can also highlight the shape of change during 
psychological therapy (Kellett, 2007), it is also indicated prior to moving onto group designs in the 
hourglass model of psychotherapy evaluation (Salkovskis, 2006).     
In the present paper, a SCED evaluating the UP treatment of an older adult with a diagnosis 
of co-morbid depression and anxiety is presented.  As no evidence has yet been produced to test 
the effectiveness of the UP in older adults with co-morbid emotional disorders, the current study is 
innovative and consistent with the hourglass model of modality evaluation (Salkovskis, 2006).  The 
study hypotheses were H1: that the UP will be well tolerated, H2: UP treatment will reduce the 
daily experience of anxiety over time in comparison to baseline, H3: UP treatment will increase 
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daily structure and improve daily mood over time compared to baseline, H4: UP will facilitate a 
reliable and clinically significant improvement to anxiety and depression. 
Method 
Design 
An A/B SCED evaluated an 8-session UP treatment with a 3-month follow-up.  The baseline 
(A) phase was spread over two assessment sessions (2-weeks duration), reflecting standard 
assessment times in routine clinical practice (McMillan & Morley, 2010).  The overall time series 
therefore consisted of 70 continuous days of an older adult patient undergoing assessment (A) and 
treatment (B) testing the Barlow et al., (2004) UP. 
Ideographic measurement 
Five ideographic anxiety and depression target measures were collaboratively designed at 
the first session and were then subsequently collected daily across baseline and intervention 
phases.  The three depression measures were (1) structure:  ?I feel like there is structure in my day ?, 
(2) hopefulness:  ?/ĨĞĞůŚŽƉĞĨƵůĂďŽƵƚŵǇŚƵƐďĂŶĚ ?ƐƉƌŽŐƌĞƐƐ ? and (3) mood:  ?I feel happy ?.  The two 
anxiety measures were (4) confidence:   ?I am confident at this point ? and (5) worry:  ?thoughts are 
whirring through my mind ?.  All daily ideographic measures were scored  ? ?ǁŽƌƐƚĞǀĞƌĨĞůƚ ? to 10 
 ?ďĞƐƚĞǀĞƌĨĞůƚ ? ?
Nomothetic measurement 
The Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) was completed 
at five time points; (1) start of baseline, (2) end of baseline, (3) mid-treatment, (4) end of treatment 
and (5) at three-month follow-up.  The HADS produces a valid and reliable measure of depression 
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(HAD-D) and anxiety (HADS-A) and is well accepted by patients (Flint & Rifat, 1996) and 
practitioners alike (Herrmann, 1996).  The measure is widely used in older populations as it 
excludes somatic symptoms and thus avoids the confounding effects of physical illness (Rapp & 
Vrana, 1989; Yesavage et al., 1983).   
Participant 
Jan (pseudonym), a 67-year old white-British female was referred for psychological 
assessment following non-response to a range of medication and support.  Jan reported symptoms 
of hopelessness, low mood, poor concentration and low levels of energy on a daily basis.  Jan also 
described worry characterised as excessive and uncontrollable, intermittent feelings of panic and 
reported symptoms of agitation, restlessness and poor sleep.  She described feeling anxious about 
everyday tasks and no longer enjoying social activities/contact.  The patient reported a lack of 
structure and purpose to her general daily life and attributed this to a transitional period 
whereupon her husband had retired from work due to ill health.  The patient was a reluctant carer 
for her partner.  :ĂŶ ?ƐĂŶǆŝŽƵƐĂŶĚĚĞƉƌĞƐƐŝǀĞƐǇŵƉƚŽŵƐŚĂĚďĞĞŶĞǀŝĚĞŶƚĨŽƌŽŶĞǇĞĂƌĂŶĚƐŚĞ
described the major impact of such symptoms upon her life.  :ĂŶ ?ƐƐǇŵƉƚŽŵƐmet DSM-5 (APA, 
2013) criteria for the diagnosis of Major Depression and Generalised Anxiety Disorder.  At 
screening, Jan scored in the moderate to severe range for both the HADS-D (15) and HADS-A (20).   
Formulation 
&ŝŐƵƌĞ ?ƉƌĞƐĞŶƚƐ:ĂŶ ?Ɛ formulation using the UP model (Barlow et al., 2004) which 
contextualised current emotional distress and symptomatology as couched in the early life 
experiences of loss and abandonment, which had created a forced independence maladaptive 
coping strategy.  Such developmental influences did not teach the patient how to manage emotions 
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and she described the need to cope with deep feelings of sadness, anxiety, anger and guilt across 
her entire adult life.  Critically, when her husband retired it changed interpersonal patterns and 
associated behavioural routines (based upon interpersonal distance) that had been relied upon for 
years in the attempt to manage emotions.  Figure 1 maps the unintended consequences of the 
ĐůŝĞŶƚ ?ƐĐŽƉŝŶŐƐƚƌĂƚĞŐŝĞƐƚŚĂƚŽŶůǇƐĞƌǀĞd to prolong her emotional suffering.  For example, the 
patient pushed her husband to increase his activity (an emotion-driven behaviour) only for this to 
increase conflict and so maintain anxiety and depression.  The formulation highlighted the key role 
of emotion in on-going unhelpful patterns and also provided hope in that working towards 
acceptance and creating personally valued goals would reduce suffering (Barlow et al., 2004).  
 
Please insert Figure 1 here 
 
Intervention  
Treatment consisted of delivery of the UP (Barlow et al., 2004). Treatment therefore 
consisted of the following, (1) validation of extant coping strategies through the formulation, (2) 
understanding the adaptive properties of emotions, (3) identifying and modifying maladaptive 
emotion-driven behaviors, (4) countering emotional avoidance and emotionally-driven behaviours 
via behavioural experiments, (5) working towards valued-driven behaviour and (6) 
accomplishments, maintenance, and relapse prevention 
Data analysis  
Stability of ideographic baseline data was assessed through graphical representations and 
the addition of trend lines.  Running totals were calculated for all ideographic measures to account 
Transdiagnostic SCED   
8 
 
for missing data points and smooth out the data for visual inspection. Two time series analyses 
compared baseline to treatment ideographic measures scores; percentage of data exceeding the 
median (PEM; McMillan & Morley, 2010) and non-overlap of all pairs (NAP; Parker & Vannest, 
2009).  PEM was employed to account for vulnerability to outliers (McMillan & Morley, 2010) and is 
particularly indicated when autocorrelation is present in time series data (Manolov, Solanas & 
Leiva, 2010).  Estimates of treatment effects based on PEM used the Wendt (2009) criteria; <70% 
indicates questionable or ineffective treatment, 70-90% indicates a moderately effective treatment 
and >90% indicates a highly effective treatment.  Due to error susceptibility in PEM, non-overlap of 
all pairs (NAP) was also employed as an ideographic measure analysis method.  Mann-Whitney U-
tests assessed for any significant difference between baseline and treatment phases in the 
ideographic measures.  Reliable and clinically significant change analyses (Evans, Margison, & 
Barkham, 1998; Jacobson & Truax, 1991) assessed change over time on the HADS.  A patient 
meeting caseness at assessment would need to score below 7 on the HADS-D and below 9 on the 
HADS-A at post-treatment to be clinically improved and lose at total of 8 points on the HADS-A and 
5 points on the HADS-D to be considered reliably improved.  Patients who simultaneously achieve 
clinical and reliable change are ůĂďĞůůĞĚĂƐ ?ƌĞĐŽǀĞƌĞĚ ? in practice-based research (Barkham, Stiles, 
Connell & Mellor-Clark, 2012).   
 
Results 
The patient attended all scheduled sessions and completed all collaboratively agreed 
homework (such as the behavioural experiments), indicating that the UP was well tolerated 
(hypothesis 1).  Figures 2 to 6 contain the graphs (hypotheses 2 and 3) of the ideographic measures 
comparing baseline to treatment study phases.  Visual inspection of trend lines do indicate a slight 
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improvement occurring during the baseline phase across most measures (except happiness, which 
deteriorated during the baseline).  Baselines did not increase monotonically and an equal number 
of individual baseline scores reduced rather than improved (e.g. daily structure, confidence and 
happiness).  Trajectories on the outcome graphs therefore indicate an acceleration of positive 
change during UP treatment in terms of daily structure, worry and confidence.  In terms of mood 
(the ideographic measure of happiness) the UP appeared to reverse the downward trend evident in 
the baseline.  However, the improvement evident during baseline concerning hopefulness 
(connected to the husband) reversed during UP treatment. 
 
Please insert Figure 2 -6 here 
 
In order to contextualise the graphical results, Table 1 reports the means and SDs across the 
baseline and UP treatment phases for ideographic measures, with associated analyses of change.  
These results demonstrate a significant improvement between baseline and treatment phases in 
ƚĞƌŵƐŽĨƚŚĞƉĂƚŝĞŶƚ ?ƐĚĂŝůǇƐƚƌƵĐƚƵƌĞ ?ŵŽŽĚ ?ĐŽŶĨŝĚĞŶĐĞĂŶĚworry.  PEM and NAP results indicate 
that all measures (except hopefulness) show a high proportion of non-overlapping data between 
baseline and treatment phases, indicating clinical change during the treatment phase.  The effect 
size analysis of the PEM results would indicate large effect sizes for structure (91%), mood (97%), 
confidence (97%) and worry (97%). 
 
Please insert Table 1 here 
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In terms of psychometric outcome (hypothesis 4), figure 7 demonstrates HADS scores over 
treatment phases.  The graph demonstrates that anxiety and depression were below the clinical 
cut-off by the end of UP treatment, with the slight relapse in anxiety and depression at follow-up 
creating a  ?hockey-stick ? style outcome pattern.  Baseline to end of treatment outcomes indicate a 
ƉĂƚŝĞŶƚƚŚĂƚŚĂĚ ?ƌĞĐŽǀĞƌĞĚ ?ŝŶƚĞƌŵƐŽĨboth anxiety (RCI = 4.31, p < 0.05 and termination score in 
the normal range) and depression (RCI = 5.39, p < 0.05 and termination score in the normal range) 
during treatment.  The final HADS-A score at follow-up was just in the clinical range, indicating 
clinically significant deterioration in anxiety. The HADS-D score remained in below the clinical cut-
off at follow-up.  The treatment to follow-up deteriorations evident on the HADS did not meet 
reliable deterioration criteria for either anxiety (RCI = 4.31, n.s.) or depression (RCI = 5.39, n.s.).   
 
Please insert Figure 7 
 
 
 
Discussion 
This study reported the first attempt to test the UP in co-morbid older adults in routine 
practice.   The SCED methodology provided a uniquely person-centred analysis of change of an 
older adult struggling with co-morbid anxiety and depression, with the UP formulation emphasising 
the key role of emotional avoidance in the maintenance of on-going difficulties.  dŚĞƉĂƚŝĞŶƚ ?Ɛ
choice of ideographic measures appeared to reflect the reality of the everyday toll of co-morbid 
anxiety and depression.  Taken as whole, the results would be described as mixed.  Despite a 
reliable and clinically significant reduction in HADS anxiety and depression during treatment 
(meeting recovery criteria), there was some evidence of (non-reliable) relapse over the follow-up 
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period in terms of anxiety, as the patient was in the clinical range at follow-up.  This vital follow-up 
ĞǀŝĚĞŶĐĞĐƌĞĂƚĞĚƚŚĞŵĂƌŬĞĚ ?ŚŽĐŬĞǇ-ƐƚŝĐŬ ?ŽƵƚĐŽŵĞƉĂƚƚĞƌŶŝŶƚŚĞ,^ ?In terms of ideographic 
change, the baseline-treatment comparisons noted significant improvements to daily structure, 
self-confidence and mood and a significant reduction to the intensity of daily worry.  The associated 
effect sizes for these improvements to structure, mood, confidence and worry were large and 
would indicate effective UP treatment (Wendt, 2009).   
No previous SCEDs of the UP have been completed in adults or older adults and therefore 
the results also throw light on the shape of change during UP treatment.  For the ideographic 
measures that significantly improved, the graphing of the outcome data illustrated that progress 
was fairly stable and progressive across the treatment phase, with an absence of sudden gains.  
Clinically, it is interesting to note that the patient did feel less hopeful after UP treatment  ? despite 
this being a statistically non-significant change.  The UP appeared to enable the patient to better 
understand the adaptive properties of emotions, with treatment helping to address emotional 
avoidance and counter emotionally-driven behaviours.  This actually enabled the patient to 
appropriately ĂĐĐĞƉƚŚĞƌŚƵƐďĂŶĚ ?ƐƌĞƚŝƌĞŵĞŶƚĂŶĚƉůĂĐĞůĞƐƐĞŵƉŚĂƐŝƐŽŶŚĞƌŚƵƐďĂŶĚ ?ƐŚĞĂůƚŚĂƐ
the sole marker for her own on-going well-being and recovery (Barlow et al., 2004).  Loss of hope 
was therefore consistent with UP treatment and the acceptance of reality by the patient.     
The findings from the present research are important in advancing the treatment of co-
morbid anxiety and depression in later life and suggest that a single transdiagnostic approach can 
be well tolerated.  The style of the UP appears to have high face validity with co-morbid patients 
and in the current study all scheduled session were attended indexing this.  Clinicians can also feel 
supported and contained by the modularised and structured clinical approach, with specific 
activities to complete at certain junctures during therapy.  The skill in applying any evidenced-based 
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psychotherapy is to always adapt and mould the method to the presentation of the patient, whilst 
remaining consistent to the evidence-base.  This solves the clinical dilemma of either slavish 
adherence to protocols versus messy eclecticism.  In the current study the person-centred UP 
formulation aided in this process of the patient ?Ɛ emotional distress being heard and understood.  
Obviously, further research is indicated concerning the acceptability and effectiveness of 
transdiagnostic approaches with older adults, guided by the hourglass model of psychotherapy 
evaluation (Salkovskis, 2006).  In terms of the head of the UP older adult evaluation hourglass, the 
next indicated steps concern testing the UP with more controlled SCEDs (such as a withdrawal 
design or testing against a phase of disorder-specific CBT) and other small N evaluations.  Testing 
the acceptability and effectiveness of UP group delivery is also indicated.    
In terms of methodological problems with the current research, trend lines indicated some 
improvement within the baseline period for four out of five of the idiographic SCED measures.  This 
instability in baselines means that change as a result of intervention are harder to evidence with 
confidence.  Unstable baselines are common in SCED (Kellett, 2007) and frequently reflect the fact 
that the patient has been offered some hope through contact, that assessment is not technically or 
interpersonally  ?ŶĞƵƚƌĂů ?ĂŶĚoften has a therapeutic action in and of itself (McMillan & Morley, 
2010).   The ideographic data was only collected during baseline and treatment phases and the 
study would have been much improved by the collection of time series data across the follow-up 
period.  This would have usefully contextualised the slight increase in anxiety observed on the 
HADS-A at follow-up and also been a good test of the durability of the UP.  As previously stated, the 
design of the current A/B SCED study was the most basic variant of the methodology and could 
have been improved by removal, addition or randomisation designs.  All the data was self-report 
and evaluation efforts would have been improved with the addition of clinician-rated outcome 
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measures.  An interesting additional data source could have been collecting a time series from the 
husband of ƚŚĞƉĂƚŝĞŶƚ ?ƐĂŶǆŝĞƚǇĂŶĚĚĞƉƌĞƐƐŝŽŶŽǀĞƌƚŚĞĐŽƵrse of assessment and treatment (or a 
behavioural measure of frequency of conflict).  The most obvious limit to any SCED is the degree to 
which results generalise to other patients.       
In conclusion, this study is the first to assess the effectiveness of the UP with an older adult 
with co-morbid anxiety and depression.  Despite acknowledged methodological limitations, this 
study offers initial encouragement concerning the adoption and further testing of the UP within 
older adult populations.  No adjustments were made to the content of the UP, but the normal 
adjustments made to the delivery of any talking therapy with older adults were observed (e.g. 
slowing of pace).  Transdiagnostic approaches appear to have the potential to offer additional 
treatment choice for older adults with co-morbid problems, who are at risk of attrition and relapse 
when treated with disorder-specific psychological models (NICE, 2009; Rybarczyk et al., 1992). Co-
morbidity is the norm and not the exception in clinical services and there is much work to do 
clinically, organisationally and research-wise to meet this clinical need.          
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Table 1 
Anxiety and depression during baseline and treatment phases 
Ideographic measure Baseline Mean 
(SD) 
UP 
treatment 
Mean (SD) 
Non-
overlap of 
all pairs 
(NAP) % 
Percentage 
of data 
exceeding 
median 
(PEM) % 
Z 
  
Daily structure  
 
1.85 (1.14) 
 
3.97 (1.30) 89 
 
91 
 
-3.867* 
    
Hopefulness 1.92 (1.40) 2.05 (1.40) 54 42 -0.425 
    
Confidence 1.31 (1.38) 4.00 (1.31) 94 97 -4.832* 
    
Mood 1.38 (1.26) 3.90 (1.50) 89 97 -4.319* 
    
Worry 1.54 (1.13) 4.87 (2.12) 96 97 -4.591* 
    
 *p<0.001; negative Z values indicate higher scores in treatment compared to baseline. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Transdiagnostic SCED   
23 
 
  
Figure 7. HADS during baseline, treatment and 3  ?month follow up 
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